Firefly Neuroscience
AIFF
17 hedge funds and large institutions have $248K invested in Firefly Neuroscience in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 17 → 17 (0)
0% less ownership
Funds ownership: 0.09% → 0.09% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
52% less capital invested
Capital invested by funds: $514K → $248K (-$266K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$22.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.49K |
| 3 |
BlackRock
New York
|
+$628 |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$163 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$23 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$19K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14.1K |
| 3 |
Renaissance Technologies
New York
|
-$13K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$1.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$931 |
AIFF Hedge Fund Activity: Q4 2022 in Review
17 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Firefly Neuroscience (AIFF) for Q4 2022, worth a combined $248K — down 52% from $514K a quarter earlier.
Fund positioning in AIFF was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 5 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $22.1K. The largest seller was United Capital Financial Advisors, exiting entirely with an estimated $19K sold.
- 17 institutional investors held Firefly Neuroscience (AIFF) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $248K of Firefly Neuroscience stock for Q4 2022, down 52% quarter-over-quarter.
- 2 funds opened new Firefly Neuroscience positions in Q4 2022 and 2 closed out, a net change of 0 holders.
- The largest Firefly Neuroscience buyer in Q4 2022 was Citadel Advisors, an estimated $22.1K added.
- The largest Firefly Neuroscience seller in Q4 2022 was United Capital Financial Advisors, an estimated $19K sold.
Based on aggregated 13F filings for Q4 2022.